Cramer’s lightning round: GXO Logistics is a buy

Cramer’s lightning round: GXO Logistics is a buy


Axsome Therapeutics Inc: “They’re trying to cure pain. … We know who didn’t do it well, and we’re not even going to mention it.”

nCino Inc: “As much as I like nCino, I like its product, it’s losing money. So, we can’t buy it.”

Cramer's lightning round: GXO Logistics is a buy

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.



Source

Novo Nordisk faces a defining year in the obesity drug market. It’s off to a dramatic start
Business

Novo Nordisk faces a defining year in the obesity drug market. It’s off to a dramatic start

Mike Doustdar, CEO of Novo Nordisk, speaks in the Oval Office during an event about weight loss drugs at the White House, Nov. 6, 2025. Andrew Caballero-Reynolds | Afp | Getty Images Novo Nordisk entered 2026 with the momentum of a historic year in more ways than one — but recent weeks have delivered more […]

Read More
Why the largest U.S. auto dealer isn’t interested in Chinese cars — for now
Business

Why the largest U.S. auto dealer isn’t interested in Chinese cars — for now

Nio cars are seen displayed at Nio House, at the Chinese electric vehicle (EV) maker’s manufacturing hub in Hefei, Anhui province, China April 2, 2025. Florence Lo | Reuters DETROIT — The largest U.S. auto dealer isn’t interested in selling vehicles from China-based brands domestically right now, its CEO said Wednesday. But it’s not necessarily […]

Read More
McDonald’s is about to report earnings. Here’s what to expect
Business

McDonald’s is about to report earnings. Here’s what to expect

A McDonald’s cheeseburger, fries, and soda arranged in Celina, Texas, US, on Tuesday, Sept. 2, 2025. Jake Dockins | Bloomberg | Getty Images McDonald’s is expected to report its fourth-quarter earnings after the bell on Wednesday. Here’s what Wall Street analysts surveyed by LSEG are expecting the company to report: Earnings per share: $3.05 expected […]

Read More